New nanoparticle can help detect cancer at early stages

01/23/2008 | Examiner (Washington, D.C.), The

Researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine have developed nanoparticles that help preserve biomarkers, which can indicate cancer and other diseases, a step that could lead to cancer detection at much earlier stages. Different biomarkers can be tested by altering the nanoparticles.

View Full Article in:

Examiner (Washington, D.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD